|
Bioadaptives Inc
BDPT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Bioadaptives Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 103
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Bioadaptives Inc net loss increased from $0 millions, to $0 millions in III. Quarter 2024,
• More on BDPT's Growth
|
|
Bioadaptives Inc realized a net loss in trailing twelve months.
Bioadaptives Inc realized cash reduction of $ -0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
3553.49 |
PE TTM
|
|
Company's Price to Sales ratio is at 4958.91.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.
• More on BDPT's Valuation
|
|
|
|
|
Bioadaptives Inc realized net loss in trailing twelve months.
Bioadaptives Inc realized cash outflow of $ -0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
3553.49 |
PE TTM
|
|
Company's Price to Sales ratio is at 4958.91.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.
• More on BDPT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com